Streetbeat News

Products Services

GANX

Gain Therapeutics shares rose following the announcement of new evidence supporting the disease-modifying activity of Gt-02287 in preclinical models of Parkinson's disease.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:26 pm

GOOGL

A U.S. judge has ordered Google to allow more competition in its app store, potentially impacting its business model and revenue from app store operations.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:25 pm

BCLI

Brainstorm Cell Therapeutics shares rose as the CEO is set to discuss the Phase 3b ALS trial at the Maxim Healthcare virtual summit.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:16 pm

SOXX

The iShares Semiconductor ETF (SOXX) has seen significant gains due to demand in AI, cloud computing, and automotive technologies. However, it is approaching a 'Death Cross,' a bearish technical indicator, amid geopolitical tensions and supply chain issues. Despite strong performance, investors should be cautious of potential volatility.

Portfolio Pulse from Surbhi Jain

October 07, 2024 | 6:13 pm

BMY

RVPH

Reviva Pharmaceuticals' Brilaroxazine shows strong efficacy in treating schizophrenia, potentially offering cognitive benefits and a better metabolic profile compared to Bristol Myers' recently FDA-approved Cobenfy. Analysts see potential for Brilaroxazine in the treatment landscape.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 6:13 pm

EG

SMCI

STZ

TLT

USO

Stocks fell as oil prices surged and 10-year yields crossed 4% due to Middle East tensions. The energy sector outperformed, with USO rising over 3%. Major indices like the S&P 500 and Dow Jones declined. Super Micro Computer Inc. surged 14% on product news, while Everest Group Ltd. and Constellation Brands Inc. faced downgrades.

Portfolio Pulse from Piero Cingari

October 07, 2024 | 6:02 pm

IBKR

Interactive Brokers (NASDAQ:IBKR) has announced that trading in Election Forecast Contracts has surpassed 1 million since their launch on October 3, 2024. These contracts allow US investors to trade predictions on political outcomes, economic data releases, and climate indicators via the ForecastEx exchange. The high demand highlights the growing relevance of political prediction markets.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 6:02 pm

GSK

PFE

Pfizer won a legal battle in London, invalidating two of GSK's RSV vaccine patents. This victory comes as Pfizer faces reduced demand for COVID-19 vaccines. Activist investor Starboard Value has invested $1 billion in Pfizer. Both companies are competing in the RSV vaccine market, projected to exceed $10 billion by 2030.

Portfolio Pulse from Vandana Singh

October 07, 2024 | 5:56 pm

BABA

MCHI

SPY

TCEHY

Chinese stocks have surged, with the MSCI China Index outperforming the S&P 500 due to policy stimulus. The iShares MSCI China ETF (MCHI) rose over 35% from Sept. 24 to Oct. 7. Major Chinese companies like Alibaba and Tencent saw significant gains. Analysts advise caution, suggesting potential pullbacks but also long-term opportunities in certain sectors.

Portfolio Pulse from Piero Cingari

October 07, 2024 | 5:49 pm